Transgene Biotek

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue0.040.140.090.090.10
Expenses1.520.270.220.210.37
EBITDA-0.19-0.08-0.08-0.07-0.22
EBIT-1.42-0.10-0.10-0.09-0.24
Profit Before Tax-1.47-0.13-0.13-0.12-0.27
Net Profit-1.47-0.13-0.13-0.12-0.27
Financial Ratios
Operating Profit Margin0.00%-80.00%-160.00%-120.00%-440.00%
Net Profit Margin0.00%-130.00%-260.00%-240.00%-540.00%
Earning Per Share (Diluted)-0.19-0.17-0.02-0.02-0.04
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ